Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Up 25.3% in November

Rockwell Medical, Inc. (NASDAQ:RMTI) saw a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 1,120,000 shares, a growth of 25.3% from the October 31st total of 893,900 shares. Based on an average daily volume of 797,600 shares, the short-interest ratio is currently 1.4 days. Approximately 4.0% of the shares of the stock are sold short.

Institutional Investors Weigh In On Rockwell Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Barclays PLC bought a new stake in Rockwell Medical during the 3rd quarter worth about $90,000. XTX Topco Ltd lifted its position in Rockwell Medical by 45.7% during the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after buying an additional 8,922 shares in the last quarter. Jane Street Group LLC bought a new stake in Rockwell Medical during the 3rd quarter worth about $534,000. State Street Corp increased its stake in shares of Rockwell Medical by 21.5% during the 3rd quarter. State Street Corp now owns 95,004 shares of the company’s stock worth $377,000 after purchasing an additional 16,800 shares during the last quarter. Finally, HighTower Advisors LLC increased its stake in shares of Rockwell Medical by 75.6% during the 3rd quarter. HighTower Advisors LLC now owns 57,413 shares of the company’s stock worth $228,000 after purchasing an additional 24,715 shares during the last quarter. 23.31% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on RMTI. StockNews.com cut Rockwell Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. HC Wainwright reduced their target price on shares of Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, November 25th. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. Finally, Rodman & Renshaw started coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price objective on the stock.

Rockwell Medical Trading Up 3.2 %

Shares of NASDAQ:RMTI opened at $2.29 on Monday. The company’s 50-day moving average price is $3.35 and its two-hundred day moving average price is $2.67. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. Rockwell Medical has a one year low of $1.16 and a one year high of $5.15. The stock has a market capitalization of $74.01 million, a PE ratio of -45.80 and a beta of 1.50.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.